CD4 and neoplasm: Since IL-17 also acts as tumor suppressor during the process of tumorigenesis by enhancing NK cell and CTL cell activation, and recruiting neutrophil, NK cell, CD4 + and CD8 + T cell infiltration into tumor tissues [9], its reduced levels would favor the development of cancer lesions.